Shiota Naoki, Yokoyama Akihito, Haruta Yoshinori, Hattori Noboru, Kohno Nobuoki
Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
J Asthma. 2011 Nov;48(9):907-13. doi: 10.3109/02770903.2011.615430. Epub 2011 Sep 26.
The association between airway inflammation and asthma control level is not clear at present.
This study aimed to explore the association by using induced sputum and asthma control status as determined by the Asthma Control Test (ACT). We also evaluated the association between the scores for each ACT question item and eosinophilic or neutrophilic airway inflammation.
The ACT and sputum induction were performed at the same time. Associations between total scores or scores for each question item and sputum eosinophil or neutrophil counts were examined. The study was approved by an Institutional Review Board.
Of the 101 patients with chronic asthma enrolled, data from 98 (controlled n = 66, uncontrolled n = 32) were analyzed [60.0 years (43.0-68.0) M:F = 34:64]. Current control status determined by the ACT was not significantly associated with eosinophilic or neutrophilic inflammation. Among the ACT items, only nocturnal symptoms were associated with sputum eosinophils: patients with a positive answer to the question had significantly higher eosinophil counts than patients with a negative answer [5.4 (2.2-17.6) versus 2.1 (0.7-7.3), respectively, p = 0.08]. Furthermore, significant correlation was found between eosinophil counts and the scores for nocturnal symptoms (rs = -0.218 p = 0.031). On the other hand, patients with rescue use of a short-acting b2-agonist (SABA) had significantly higher sputum neutrophil counts than non-SABA users [73.4 (52.8-83.4) versus 61.0 (36.3-74.8), respectively, p = 0.031]. The other ACT items were not significantly associated with sputum neutrophils. The neutrophil count correlated significantly with the frequency of rescue SABA use (rs = -0.218 p = 0.031).
Asthma control level evaluated by the ACT was not associated with airway eosinophilic or neutrophilic inflammation. However, the frequency of nocturnal symptoms was associated with sputum eosinophilia, and the frequency of rescue SABA use was associated with sputum neutrophilia.
目前气道炎症与哮喘控制水平之间的关联尚不清楚。
本研究旨在通过使用诱导痰以及哮喘控制测试(ACT)所确定的哮喘控制状态来探究两者之间的关联。我们还评估了ACT各问题项得分与嗜酸性粒细胞或中性粒细胞气道炎症之间的关联。
同时进行ACT和痰液诱导。检查总分或各问题项得分与痰液嗜酸性粒细胞或中性粒细胞计数之间的关联。该研究经机构审查委员会批准。
在纳入的101例慢性哮喘患者中,分析了98例患者的数据(控制良好组n = 66,控制不佳组n = 32)[年龄60.0岁(43.0 - 68.0),男:女 = 34:64]。ACT所确定的当前控制状态与嗜酸性粒细胞或中性粒细胞炎症无显著关联。在ACT各项中,只有夜间症状与痰液嗜酸性粒细胞有关:对该问题回答为阳性的患者嗜酸性粒细胞计数显著高于回答为阴性的患者[分别为5.4(2.2 - 17.6)和2.1(0.7 - 7.3),p = 0.08]。此外,发现嗜酸性粒细胞计数与夜间症状得分之间存在显著相关性(rs = -0.218,p = 0.031)。另一方面,使用短效β2受体激动剂(SABA)进行急救的患者痰液中性粒细胞计数显著高于未使用SABA的患者[分别为73.4(52.8 - 83.4)和61.0(36.3 - 74.8),p = 0.031]。ACT的其他项与痰液中性粒细胞无显著关联。中性粒细胞计数与SABA急救使用频率显著相关(rs = -0.218,p = 0.031)。
ACT评估的哮喘控制水平与气道嗜酸性粒细胞或中性粒细胞炎症无关。然而,夜间症状的频率与痰液嗜酸性粒细胞增多有关,SABA急救使用频率与痰液中性粒细胞增多有关。